SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat
16 references·0 citing·37 second hop
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat (2019)Psilocybin lacks antidepressant-like effe…Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression (2018)Effects of N,N-Dimethyltrypta…Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Rapid and sustained symptom r…Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psilocybin with psychological…Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin produces substanti…Phenomenology, Structure, and Dynamic of Psychedelic States (2016)Phenomenology, Structure, and…Effect of Hallucinogens on Unconditioned Behavior (2016)Effect of Hallucinogens on Un…Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015)Psilocybin-assisted treatment…Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat (2015)Behavioural and neurotoxic ef…Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction (2014)Pilot study of the 5-HT 2A R …Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning (2013)Effects of psilocybin on hipp…Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010 (2013)Burden of Depressive Disorder…Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers (2011)Psilocybin-Induced Deficits i…Cost of disorders of the brain in Europe 2010 (2011)Cost of disorders of the brai…Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Hallucinogens Recruit Specifi…5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride (1999)5-HT Modulation of Dopamine R…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis (1997)Psilocybin – Summary of knowledge and new perspectives (2013)Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years (2016)Hallucinogens (2004)The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (2010)Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders (2020)Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo (2021)The varieties of religious experience: A study in human nature. (1902)Universals in the Content and Structure of Values: Theoretical Advances and Empirical Tests in 20 Countries (1992)Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. (2002)Neural correlates of the LSD experience revealed by multimodal neuroimaging (2016)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness (2008)The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (2014)Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (2022)Comprehensive Textbook of Psychiatry (1967)Comprehensive Textbook of Psychiatry (1968)The size and burden of mental disorders and other disorders of the brain in Europe 2010 (2011)The association between social relationships and depression: A systematic review (2015)Scaling-up treatment of depression and anxiety: a global return on investment analysis (2016)Sleep, insomnia, and depression (2019)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Diagnostic and Statistical Manual of Mental Disorders (2013)Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study (2019)New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis (2019)Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta‐analysis (2021)Manual for the State-Trait Anxiety Inventory (1970)The Hospital Anxiety and Depression Scale (1983)Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. (1985)Psychedelics (2016)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Psychedelics Promote Structural and Functional Neural Plasticity (2018)Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Trial of Psilocybin versus Escitalopram for Depression (2021)
this work references cited by second hop

References

  • 2013Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 20103,115 cited
  • 2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
  • 2011Cost of disorders of the brain in Europe 20101,720 cited
  • 2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited
  • 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
  • 2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 2007Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior922 cited
  • 2014Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction913 cited
  • 19995-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride304 cited
  • 2016Phenomenology, Structure, and Dynamic of Psychedelic States282 cited
  • 2013Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning265 cited
  • 2011Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

230 cited
  • 2018Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression171 cited
  • 2016Effect of Hallucinogens on Unconditioned Behavior109 cited
  • 2015Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat102 cited
  • Cited by

    No citing works inside the corpus for this window.